全文获取类型
收费全文 | 5807篇 |
免费 | 418篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 84篇 |
儿科学 | 112篇 |
妇产科学 | 120篇 |
基础医学 | 765篇 |
口腔科学 | 146篇 |
临床医学 | 598篇 |
内科学 | 1008篇 |
皮肤病学 | 86篇 |
神经病学 | 541篇 |
特种医学 | 256篇 |
外科学 | 739篇 |
综合类 | 88篇 |
一般理论 | 4篇 |
预防医学 | 687篇 |
眼科学 | 108篇 |
药学 | 371篇 |
中国医学 | 5篇 |
肿瘤学 | 528篇 |
出版年
2023年 | 30篇 |
2022年 | 62篇 |
2021年 | 140篇 |
2020年 | 70篇 |
2019年 | 131篇 |
2018年 | 147篇 |
2017年 | 122篇 |
2016年 | 93篇 |
2015年 | 106篇 |
2014年 | 178篇 |
2013年 | 278篇 |
2012年 | 468篇 |
2011年 | 521篇 |
2010年 | 250篇 |
2009年 | 210篇 |
2008年 | 380篇 |
2007年 | 399篇 |
2006年 | 374篇 |
2005年 | 369篇 |
2004年 | 325篇 |
2003年 | 294篇 |
2002年 | 292篇 |
2001年 | 68篇 |
2000年 | 51篇 |
1999年 | 61篇 |
1998年 | 59篇 |
1997年 | 32篇 |
1996年 | 34篇 |
1995年 | 38篇 |
1994年 | 42篇 |
1993年 | 45篇 |
1992年 | 31篇 |
1991年 | 26篇 |
1990年 | 20篇 |
1989年 | 24篇 |
1987年 | 19篇 |
1986年 | 29篇 |
1985年 | 15篇 |
1984年 | 22篇 |
1983年 | 23篇 |
1982年 | 27篇 |
1981年 | 31篇 |
1980年 | 40篇 |
1979年 | 18篇 |
1978年 | 21篇 |
1977年 | 20篇 |
1976年 | 21篇 |
1975年 | 16篇 |
1974年 | 16篇 |
1971年 | 14篇 |
排序方式: 共有6246条查询结果,搜索用时 359 毫秒
21.
22.
Ahsan Y Khan Joe Carrithers Sheldon H Preskorn Rex Lear Stephen R Wisniewski A John Rush Diane Stegman Colleen Kelley Karen Kreiner Andrew A Nierenberg Maurizio Fava 《Annals of clinical psychiatry》2006,18(2):91-98
BACKGROUND: The purpose of this paper is to use demographic and clinical data from a large diverse group of outpatients diagnosed with non-psychotic major depression to investigate the validity of the DSM-IV concept of melancholic depression. METHODS: Baseline clinical and demographic data were collected on 1500 outpatients (1456 of whom melancholia could be determined) with non-psychotic major depressive disorder (MDD) participating in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Depressive symptom severity was assessed by clinical telephone interview using the 17-item Hamilton Rating Scale for Depression (HRS-D17) and the 30-item Inventory of Depressive Symptomatology (IDS-C30). The types and degrees of concurrent psychiatric symptoms were measured using a self report, the Psychiatric Diagnostic Screening Questionnaire (PDSQ), by recording the number of items relevant to each diagnostic category endorsed by study participants. RESULTS: Adjusting for severity of depression (as measured by the total HRS-D17 scores), no differences were found in the rate of melancholic depression by race, marital status, education, employment status, family history of depression, primary care versus specialty care, monthly income, and degree of psychiatric and medical co-morbidity. Melancholic depression was significantly more likely in men than women. Melancholic depression after adjustment for severity was associated with a slightly younger age at study entry, as well as with greater illness severity, and slightly shorter duration of current episode. Hispanic ethnicity was associated with lower melancholic depression rates at the .06 level of significance. CONCLUSIONS: Among outpatients with MDD, melancholic features were less likely in Hispanic patients, but more likely in slightly younger patients and in men. Melancholic features were also related to a slightly shorter current episode. These findings are consistent with the notion that external socio-demographic factors do not play an important role in the pathophysiology of melancholic depression. 相似文献
23.
Joe Pixler 《Journal of healthcare risk management》2004,24(1):29-29
24.
25.
Kohsuke Sasaki Daniel Pinkel Masato Tsukahara Ichiro Murano Joe W Gray 《Pathology international》1994,44(2):145-150
A human chromosomal translocation t(8;9) was detected using two-color fluorescence in situ hybridization with probes capable of staining the entire lengths of each of these chromosomes. The chromosome 8 probe was labeled with biotin and detected with Texas red, while the chromosome 9 probe was labeled with AAF and detected with FITC . In normal metaphase spreads, two metaphases from the proband, two red, one green and one part red and part green derivative chromosome were seen. The bicolor chromosome corresponded to translocation of a chromosome 8 segment to the distal part of the q region of one chromosome 9, as originally indicated by banding analysis. In interphase nuclei of the proband, four domains with bright fluorescence were recognized in many nuclei. Two were red, one was green, and the fourth had portions of both colors, indicating the presence of the translocation. 相似文献
26.
27.
Robert C Bast Hans Lilja Nicole Urban David L Rimm Herbert Fritsche Joe Gray Robert Veltri George Klee Andrew Allen Nam Kim Steven Gutman Mark A Rubin Andrew Hruszkewycz 《Clinical cancer research》2005,11(17):6103-6108
A group of investigators met at a Specialized Programs of Research Excellence Workshop to discuss key issues in the translation of biomarker discovery to the development of useful laboratory tests for cancer care. Development and approval of several new markers and technologies have provided informative examples that include more specific markers for prostate cancer, more sensitive tests for ovarian cancer, more objective analysis of tissue architecture and an earlier indication of response to treatment in breast cancer. Although there is no clear paradigm for biomarker development, several principles are clear. Marker development should be driven by clinical needs, including early cancer detection, accurate pretreatment staging, and prediction of response to treatment, as well as monitoring disease progression and response to therapy. Development of a national repository that uses carefully preserved, well-annotated tissue specimens will facilitate new marker development. Reference standards will be an essential component of this process. Both hospital-based and commercial laboratories can play a role in developing biomarkers from discovery to test validation. Partnering of academe and industry should occur throughout the process of biomarker development. The National Cancer Institute is in a unique position to bring together academe, industry, and the Food and Drug Administration to (a) define clinical needs for biomarkers by tumor type, (b) establish analytic and clinical paradigms for biomarker development, (c) discuss ways in which markers from different companies might be evaluated in combination, (d) establish computational methods to combine data from multiple biomarkers, (e) share information regarding promising markers developed in National Cancer Institute-supported programs, and (f) exchange data regarding new platforms and techniques that can accelerate marker development. 相似文献
28.
29.
30.
Michael Horowitz Phillip Purdy Hal Unwin George Carstens Ralph Greenlee Joe Hise Tom Kopitnik Hunt Batjer Nancy Rollins Duke Samson 《Annals of neurology》1995,38(1):58-67
Thrombosis of the cerebral dural venous sinuses, cortical draining veins, and deep cerebral veins is a rare clinical finding. Because of its low incidence and multiple etiologies, the optimum therapy for this condition will only be elucidated by a multicenter, randomized prospective study. At our institution, we favor early and aggressive management of cerebral venous sinus thrombosis with transfemoral, venous intradural infusions of the fibrinolytic agent urokinase. To date, treatment of only 13 patients using this technique has been reported in the English literature. This report adds 12 more such treated patients. Despite the presence of preinfusion infarcts in 5 patients, four of which were hemorrhagic, we incurred no major therapeutic morbidity. Functional sinus patency was achieved in 11 of 12 patients, with our only true failure occurring in an individual with symptoms of at least 2 months' duration. Good to excellent clinical outcome was achieved in 10 of 11 patients (one newborn had inadequate follow-up). 相似文献